ABBV Competitors & Alternatives
Compare AbbVie Inc with similar stocks in the same industry
Drug Manufacturers - General
ABBV
Main Stock$234.52
Tradestie Score
58
Market Cap
$431.71B
P/E Ratio
106.1
Revenue Growth
0.1%
Analyst Upside
+8.1%
Top Competitors
17 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JNJ
Johnson & Johnson
|
$237.18
|
$448.07B | 26.5 | 56 | Compare |
|
NVO
Novo-Nordisk A/S
|
$46.77
|
$262.92B | 10.1 | 57 | Compare |
|
AZN
AstraZeneca PLC
|
$180.22
|
$261.56B | 26.3 | 52 | Compare |
|
NVS
Novartis AG
|
$152.89
|
$254.99B | 21.0 | 56 | Compare |
|
ABT
Abbott Laboratories
|
$90.63
|
$232.30B | 24.8 | 59 | Compare |
|
MRK
Merck & Co., Inc.
|
$118.90
|
$225.13B | 32.1 | 59 | Compare |
|
AMGN
Amgen Inc
|
$347.42
|
$160.70B | 23.5 | 59 | Compare |
|
PFE
Pfizer Inc.
|
$24.93
|
$154.70B | 19.2 | 53 | Compare |
|
GILD
Gilead Sciences Inc
|
$125.69
|
$137.92B | 16.8 | 58 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$41.63
|
$121.27B | 18.4 | 43 | Compare |
More ABBV Analysis
Data updated: Jun 23, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
17 stocks in this industry